(MENAFN- PR Newswire)
NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ReneSola Ltd. ('ReneSola' or the 'Company') (NYSE: SOL ). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
The investigation concerns whether ReneSola and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On December 2, 2021, Grizzly Research ('Grizzly') published a research report on ReneSola entitled 'We believe ReneSola is a Fraudulent Company; Most Projects Never Existed.' Citing 'on the ground due diligence, filings review, and communications with local municipalities in Europe', The Grizzly report alleged, among other things, 'that ReneSola has been vastly misrepresenting its project development pipeline.'
On this news, ReneSola's stock price fell $0.50 per share, or 7.62%, to close at $6.06 per share on December 2, 2021.
The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See .
CONTACT: Robert S. WilloughbyPomerantz LLP[email protected] 888-476-6529 ext. 7980
SOURCE Pomerantz LLP
MENAFN17012022003732001241ID1103552506
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.